ReCode Therapeutics Competitors and Similar CompaniesClear all

ReCode Therapeutics's competitors and similar companies include BillionToOne.
ReCode Therapeutics
ReCode Therapeutics
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
BillionToOne
BillionToOne
BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.
Founding Date
Founding Date
2015
Founding Date
2016
Type
Type
Private
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Menlo Park, US HQ
Employees
Employees
1062% decrease
Employees
620

Funding

Total funding raised
Total funding raised
$ 82m
Total funding raised
$ 87.5m
For sources of this data, please see the company profile

View Company Profiles

BillionToOne
HQ
Menlo Park, US
Employees
620

BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.

View company